How would you approach treatment of active inflammatory arthritis in a patient with MCTD (+RNP/+Chromatin) and stable ILD who has failed MMF, azathioprine and methotrexate?
Would you consider belimumab over a TNF inhibitor for inflammatory arthritis? Which agent would be more beneficial for the lung disease?
Answer from: at Academic Institution
I'd think about Actemra to treat both ILD (with the scleroderma approval) and arthritis.
Sign in or Register to read more
Answer from: at Community Practice
I second Dr. @Cuoghi Edens's advice. This is VERY similar to a patient of mine. She (UCTD with inflammatory arthritis and interstitial lung disease after failing numerous agents) went into remission after adding tocilizumab to her hydroxychloroquine.The other agent I'd consider is abatacept. There a...